Search results

ANSTO is privileged to be home to an incredible array of outstanding women in science. On the International Day of Women and Girls in Science we wanted to thank each one. Thank you!

The instrument is designed to measure inelastic neutron scattering, or do neutron spectroscopy.

Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science 

ANSTO has been awarded an Athena Bronze Institution Award, acknowledging our dedication to improving workplace equality, diversity and inclusion.

ANSTO continues a longstanding, mutually-beneficial research relationship with the University of Wollongong following the signing of a strategic agreement this week.

ANSTO's Graduate Program develops the next generation of Australian business and science leaders, by providing the best and brightest postgraduate students with a two-year rotation cycle, tailored to match your talents, goals and interests.

ANSTO providing support to emergency services, closed to non-essential staff.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.

Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

Nuclear safety expert discusses Fukushima